Lemildipine is a calcium channel blocker used for its neuroprotective effects against delayed neuronal death (DND) in the hippocampal CA1 subfield following transient forebrain ischemia, with protective effects lasting up to 4 weeks; it also exhibits antihypertensive activity, producing a dose-dependent decrease in systolic blood pressure in spontaneously hypertensive rats (SHR), and shows mild blood pressure-lowering effects in normal Wistar rats, with a hypotensive potency 1.4 times greater than that of nifedipine.